Clinical trials: BDD

Hemophilia A

A Study of BAX 888 in Male Adults With Severe Hemophilia A

• Completed
• Age: 18 to 75 years
• Phase 1/2
• Results posted

The main aim of this study is to check if there are side effects from BAX 888 and to determine the dose of BAX 888 for treating severe hemophilia A in male adults.

Trial name

NCT03370172

Testing

BAX 888

Where

26 sites in United States, Austria and 4 more

Volunteers

4 people

Sponsor

Baxalta now part of Shire